61686-65-5

Basic information

• Product Name: PYRIDINE, 2,5-DIBROMO-3-(BROMOMETHYL)-
• Synonyms: PYRIDINE, 2,5-DIBROMO-3-(BROMOMETHYL)-;2,5-Dibromo-3-(bromomethyl)pyridine
• CAS NO: 61686-65-5
• Molecular Formula: C₆H₄Br₃N
• Molecular Weight: 329.817
• Mol File: 61686-65-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 334.4 °C at 760 mmHg
• Flash Point: 156 °C
• Appearance: /
• Density: 2.282 g/cm³
• Vapor Pressure: 0.000249mmHg at 25°C
• Refractive Index: 1.644
• CAS DataBase Reference: PYRIDINE, 2,5-DIBROMO-3-(BROMOMETHYL)-(CAS DataBase Reference)
• NIST Chemistry Reference: PYRIDINE, 2,5-DIBROMO-3-(BROMOMETHYL)-(61686-65-5)
• EPA Substance Registry System: PYRIDINE, 2,5-DIBROMO-3-(BROMOMETHYL)-(61686-65-5)

Safety Data

• Hazardous Substances Data: 61686-65-5(Hazardous Substances Data)

Usage

General Description

2,5-Dibromo-3-(bromomethyl)pyridine is a chemical compound with the molecular formula C7H5Br3N. It is a dibromo derivative of pyridine, containing two bromine atoms and a bromomethyl group attached to the pyridine ring. PYRIDINE, 2,5-DIBROMO-3-(BROMOMETHYL)- is commonly used as a building block in organic synthesis, particularly in the preparation of pharmaceuticals, agrochemicals, and other fine chemicals. It is also used as a reagent in the production of various chemical intermediates. The chemical properties of 2,5-dibromo-3-(bromomethyl)pyridine make it valuable for a wide range of applications in the chemical industry.

InChI:InChI=1/C6H4Br3N/c7-2-4-1-5(8)3-10-6(4)9/h1,3H,2H2

Upstream product

• 3430-21-5 5-bromo-3-methyl-pyridin-2-ylamine 
• 3430-18-0 2,5-dibromo-3-methylpyridine 

Downstream Products

• 61686-64-4 1-benzyloxy-9,10-dihydro-2,9-diazaphenanthrene 
• 61686-67-7 1-benzyloxy-2,9-diazaphenanthrene 
• 7344-61-8 perlolidine 
• 61686-62-2 2-benzyloxy-5-dibromo-3-[(N-phenyl)aminomethyl]pyridine 
• 1612855-02-3 C₅₀H₆₁N₉O₈S 
• 61686-66-6 2,5-dibromo-3-[(N-phenyl)aminomethyl]pyridine 

Relevant articles and documents

As hepatitis c inhibitor spiro compound and its use in medicine

The invention provides a spiro compound serving as a hepatitis c inhibitor and application thereof in a medicine. The compound is a compound as shown in a formula (I) or a stereisomer, a geometric isomer, a tautomer, nitric oxide, an aquo-complex, a solvate, a metabolite, pharmaceutically acceptable salt or prodrug of the compound as shown in the formula (I). The invention also provides a pharmaceutical composition containing the compound, application of the compound and the pharmaceutical composition in inhibition of HCV (Hepatitis C Virus) copy and HCV virus protein, as well as the application of the compound and the pharmaceutical composition in prevention, handling, treatment or relieving of HCV infection or hepatitis c disease for a patient. The formula I is as shown in the specification.

Dihydropyrrolopyridine inhibitors of ROR-gamma

Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions co

Synthesis of the grass alkaloid perlolidine through a pyridyne cyclisation reaction

A synthesis of the grass alkaloid perlolidine is described in which the key step involves the pyridyne cyclisation of 2-benzyloxy-5-bromo-3-[(N-phenyl) aminomethyl] pyridine.